Silverarc-Capital-Management

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
69
Total Value
488995340
Accession Number
0001420506-25-001107
Form Type
13F-HR
Manager Name
Silverarc-Capital-Management
Data Enrichment
87% identified
60 identified9 unidentified

Holdings

69 positions
Manager:
Search and click to pin securities to the top
Page 2 of 4
00973Y908
Shares:180.6K
Value:$7.3M
Gossamer Bio, Inc.
Shares:6.3M
Value:$7.0M
GILEAD SCIENCES, INC.
Shares:62.0K
Value:$7.0M
G4444H101
Shares:613.4K
Value:$6.9M
05479K106
Shares:2.7M
Value:$6.8M
Praxis Precision Medicines, Inc.
Shares:166.1K
Value:$6.3M
Mineralys Therapeutics, Inc.
Shares:338.4K
Value:$5.4M
COMPUGEN LTD
Shares:2.9M
Value:$4.2M
Tarsus Pharmaceuticals, Inc.
Shares:81.3K
Value:$4.2M
Alkermes plc.
Shares:124.9K
Value:$4.1M
OCULAR THERAPEUTIX, INC
Shares:551.6K
Value:$4.0M
BridgeBio Pharma, Inc.
Shares:111.0K
Value:$3.8M
Kura Oncology, Inc.
Shares:581.4K
Value:$3.8M
Celldex Therapeutics, Inc.
Shares:206.0K
Value:$3.7M
Dianthus Therapeutics, Inc. /DE/
Shares:190.3K
Value:$3.5M
MADRIGAL PHARMACEUTICALS, INC.
Shares:10.3K
Value:$3.4M
CERUS CORP
Shares:2.5M
Value:$3.4M
TELA Bio, Inc.
Shares:2.8M
Value:$3.4M
Centessa Pharmaceuticals plc
Shares:232.8K
Value:$3.3M
Trevi Therapeutics, Inc.
Shares:530.0K
Value:$3.3M